Data / Form D filings / IDENIX PHARMACEUTICALS INC
IDENIX PHARMACEUTICALS INC: Form D filing
IDENIX PHARMACEUTICALS INC, a pharmaceuticals company in Cambridge, MA, filed a Form D with the SEC in 2011. The latest, on April 22, 2011, reports $5 million sold of a $5 million offering to 1 investor.
Find out what IDENIX PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 60 HAMPSHIRE STREET, Cambridge, MA, 02139
- Phone
- (617) 995-9800
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1093649
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 22, 2011 | New notice | $4,999,999 | $4,999,999 | $0 | 1 | Apr 13, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tamar D. Howson | Director | |
| Anthony E. Rosenberg | Director | |
| Douglas J. Mayers | Executive Officer | |
| Robert E. Pelzer | Director | |
| Wayne T. Hockmeyer | Director | |
| Charles W. Cramb | Director | |
| Thomas R. Hodgson | Director | |
| Maria D. Stahl | Executive Officer | |
| Paul J. Fanning | Executive Officer | |
| Denise E. Pollard-Knight | Director | |
| David N. Standring | Executive Officer | |
| Daniella C. Beckman | Executive Officer | |
| Ronald C. Renaud, Jr. | Executive Officer, Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Apr 18, 2011 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what IDENIX PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.